文献速递免疫规划妇幼与学校卫生

乙型肝炎疫苗单独接种可能足以预防HBsAg(+)/HBeAg(-)母亲的新生儿乙型肝炎病毒传播

Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
PubMed 文献 · Vaccine · 2016-11-25

本研究前瞻性比较了单独接种乙型肝炎疫苗与疫苗联合乙型肝炎免疫球蛋白(HBIG)在HBsAg(+)/HBeAg(-)母亲的新生儿中预防HBV传播的效果。结果显示,两组围产期HBV传播率无差异,单独接种组抗-HBs应答率与联合组相当,且7月龄时抗-HBs几何平均浓度更高。结论认为单独接种疫苗可能足以预防此类新生儿HBV传播。

要点

  • 单独接种疫苗组与联合HBIG组围产期HBV传播率分别为0.0%(0/132)和0.1%(1/752),无统计学差异(p=1.000)。
  • 7月龄时单独接种组抗-HBs应答率为97.7%(129/132),联合组为98.5%(740/751),两组无显著差异(p=0.758)。
  • 单独接种组7月龄抗-HBs几何平均浓度显著高于联合组(1555.3 mIU/mL vs 654.9 mIU/mL,p<0.0001)。

核心结论

  • 对于HBsAg(+)/HBeAg(-)母亲的新生儿,单独接种乙型肝炎疫苗可能足以预防HBV传播。

研究设计与样本

  • 前瞻性研究,因伦理原因无法随机分组,按地区实际策略入组:广西壮族自治区实施单独疫苗策略,江苏省实施疫苗联合HBIG策略,纳入HBsAg(+)/HBeAg(-)母亲的新生儿。
  • 所有新生儿在0、1、6月龄接种三剂重组酵母乙型肝炎疫苗,联合组另在出生时加用HBIG。
  • 7月龄时共采集132名广西新生儿和752名江苏新生儿血清;12月龄时随访部分新生儿。

主要发现

  • 7月龄时围产期HBV传播率:联合HBIG组0.1%(1/752) vs 单独疫苗组0.0%(0/132),p=1.000。
  • 7月龄时抗-HBs应答率:单独疫苗组97.7%(129/132) vs 联合HBIG组98.5%(740/751),p=0.758。
  • 7月龄时抗-HBs几何平均浓度:单独疫苗组1555.3 mIU/mL vs 联合HBIG组654.9 mIU/mL,p<0.0001。
  • 12月龄时抗-HBs保护水平维持率:未接受HBIG组97.4%(596/612) vs 接受HBIG组98.3%(118/120),p=0.771。
  • 12月龄时抗-HBs几何平均浓度:接受联合预防组210.7 mIU/mL vs 未接受HBIG组297.0 mIU/mL,p=0.011。

临床怎么用

  • 原文结论认为单独接种疫苗可能足以预防HBsAg(+)/HBeAg(-)母亲的新生儿HBV传播。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: To prospectively evaluate the efficacy of vaccine alone compared with vaccine plus HBIG for preventing HBV transmission in neonates of HBsAg (+)/HBeAg (-) mothers. METHODS: Combined immunization is currently recommended for neonates of HBsAg (+) mothers in China. As a result, a randomized design is infeasible due to ethical reasons. In practice, Guangxi Zhuang Autonomous Region and Jiangsu Province implement vaccine alone and vaccine plus HBIG strategies for neonates born to HBsAg (+)/HBeAg (-) mothers, respectively. We alternatively enrolled neonates of HBsAg (+)/HBeAg (-) mothers from these two regions. Three doses of a recombinant yeast-derived hepatitis B vaccine were given at 0, 1 and 6months with or without HBIG at birth. RESULTS: At 7months, sera were collected from 132 neonates in Guangxi Zhuang Autonomous Region and 752 neonates in Jiangsu Province. Baseline characteristics of both mothers and neonates were comparable in the two regions. No differences were revealed regarding the occurrence of perinatal HBV transmission with or without HBIG at birth [0.1% (1/752) vs. 0.0% (0/132), p=1.000]. The anti-HBs response rates were 97.7% (129/132) and 98.5% (740/751) for the neonates with vaccine alone and with HBIG (p=0.758), respectively. Vaccine alone induced a significantly higher anti-HBs GMC as compared to vaccine plus HBIG at 7months of age (1555.3mIU/mL vs. 654.9mIU/mL, p<0.0001). At 12months of age, protective levels of anti-HBs remained in 97.4% (596/612) and 98.3% (118/120) of the neonates receiving and not receiving HBIG, respectively (p=0.771). The neonates receiving combined prophylaxis had a markedly lower anti-HBs GMC (210.7mIU/mL vs. 297.0mIU/mL, p=0.011). Horizontal HBV transmission occurred in none of the successfully immunized neonates for both compared groups at 12months of age. CONCLUSIONS: Vaccine alone may be enough for preventing HBV transmission in neonates of HBsAg (+)/HBeAg (-) mothers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lu Y, Liang XF, Wang FZ, et al. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers. Vaccine. 2016. PMID: 27894717. doi:10.1016/j.vaccine.2016.11.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。